Sign in
  • R&D
  • Clinical
  • Commercial
    • Brand & Marketing
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
    • Winners of LSV Top Industry Leaders Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
LogoLifeNewsLife Science
LogoFashion Trends and Culture
  • R&D
    • Research & Development

      Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

      August 31, 2025
      Research & Development

      Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

      July 30, 2025
      Research & Development

      $20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

      July 11, 2025
      Research & Development

      Scientists Identify New Target to Prevent Cancer from Spreading to Bones

      May 22, 2025
  • Clinical
    • Clinical

      Amgen reports Vesalius-CV topline showing Repatha reduces MACE in primary-prevention patients

      October 3, 2025
      Clinical

      Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

      September 30, 2025
      Clinical

      Hansa Biopharma Reports Phase III Success for Imlifidase in Kidney Transplant Patients

      September 29, 2025
      Clinical

      Eli Lilly Ends One Bimagrumab Trial in Obesity Patients with Diabetes

      September 29, 2025
  • Commercial
    • AllBrand & Marketing
      Commercial

      Chiesi and Arbor Biotechnologies Enter $2 Billion Gene Therapy Partnership for Rare Liver Disease

      October 6, 2025
      Commercial

      Kyorin Secures Japanese Rights to Hinge Bio’s Preclinical Lupus Therapy HB2198 in $10M Deal

      October 3, 2025
      Commercial

      Akero’s MASH Success Helps Roche Acquire 89bio For $3.5B

      October 3, 2025
  • Technology
    • Technology

      Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

      July 7, 2025
      Technology

      J&J MedTech presents the first Ottava surgical robot clinical cases

      April 17, 2025
      Commercial

      Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

      October 23, 2024
      Technology

      PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

      September 26, 2024
  • Insights
    • Insights

      Reg impact assessment next in GenAI’s sights, experts claim

      June 26, 2025
      Insights

      The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

      December 1, 2024
      Insights

      Improving life science R&D outcomes with AI

      November 8, 2024
      Insights

      The medical device sector’s surging regulatory burden: how are suppliers coping?

      October 12, 2024
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
    • Winners of LSV Top Industry Leaders Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial
type here...
Facebook
Linkedin
Twitter
Home Tags Israel

Tag: Israel

NRx Pharmaceuticals | signs deal | homegrown | Covid-19 vaccine| 2021

NRx Pharmaceuticals signs deal for clinical trials of Israel’s homegrown Covid-19...

Editorial Team - July 20, 2021 0
12Page 1 of 2

Editor Picks

AdvanCell Bags $112M in Series C Funding For Alpha Radiopharma Trial

February 4, 2025

Disco Pharmaceuticals Unveils Surfaceome Mapping for Enhanced Cancer Therapeutics

January 17, 2024

Biogen Secures Ex-U.S. Rights to Dravet Syndrome Treatment

February 19, 2025

Must Read

Rocket abandons its attempt to obtain FDA approval for bone marrow gene therapy

October 7, 2025

To raise money for the immunotherapy readout, Bolt cuts staff

October 6, 2025

Chiesi and Arbor Biotechnologies Enter $2 Billion Gene Therapy Partnership for Rare Liver Disease

October 6, 2025

Hot Topics

  • Clinical354
  • Commercial339
  • Regulatory275
  • Research & Development101
  • Manufacturing67
  • Newsletter59
  • Technology40
  • News31
Logo

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Contact us: reachout(at)lifescivoice.com

Follow Us

Facebook
Instagram
Linkedin
Twitter

© Copyright - Life Sciences Voice

  • R&D
  • Clinical
  • Commercial
  • Technology
  • Insights
  • Podcast
  • Awards
    • LSV Top Industry Leaders Award 2025 Nominations
    • LSV Rising Stars Award 2025 Winner List
    • Winners of LSV Top Industry Leaders Award 2024
  • More
    • Manufacturing
    • Regulatory
    • Editorial